Global Gastric Cancer Diagnostic Procedure Market Analysis 2024, Forecast To 2033

The gastric cancer diagnostic procedure market has witnessed strong growth, with its size growing from $1.32 billion in 2023 to $1.43 billion in 2024, reflecting a CAGR of 8.0%. This growth is attributed to advancements in biopsy techniques, increased research funding, discoveries in biomarkers, improved pathological analysis, and changes in screening guidelines. Looking ahead, the market is expected to continue its robust growth, reaching $1.88 billion by 2028, with a CAGR of 7.1%. This growth is driven by the rise in point-of-care testing, introduction of novel biomarkers, adoption of next-generation sequencing, and enhanced endoscopic imaging modalities. Additionally, major trends in the forecast period include the integration of nanotechnology, utilization of big data analytics, application of microbiota analysis, increased patient-centric approaches, and the role of telehealth in diagnostics.